Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel backs Bristol diabetes drug after prior rejection
FDA panel backs Bristol diabetes drug after prior rejection
FDA panel backs Bristol diabetes drug after prior rejection
Submitted by
admin
on December 12, 2013 - 5:01pm
Source:
Yahoo/Reuters
News Tags:
FDA
advisory panels
Bristol-Myers Squibb
diabetes
Dapagliflozin
Headline:
FDA panel backs Bristol diabetes drug after prior rejection
Do Not Allow Advertisers to Use My Personal information
